Download PDF
Thromb Haemost 1997; 78(01): 382-385
DOI: 10.1055/s-0038-1657556
Controversial issues in oral anticoagulant therapy
Schattauer GmbH Stuttgart

Antithrombotic Therapy Following Heart Valve Replacement

Alexander G G Turpie
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Starr A. Late complications of aortic valve replacement with cloth-covered composite-seat prostheses. Annals Thorac Surg 19: 289 1975;
    CrossrefPubMedGoogle Scholar
  • 2 Larsen GL, Alexander JA, Stanford W. Thromboembolic phenomena in patients with prosthetic aortic valves who did not receive anticoagulants. Ann Thorac Surg 1977; 12: 323
    PubMedGoogle Scholar
  • 3 Limet R, Lepage G, Grondin CM. Thromboembolic complications with the cloth-covered Starr-Edwards aortic prosthesis in patients not receiving anticogulants. Ann Thorac Surg 1977; 23: 529
    CrossrefPubMedGoogle Scholar
  • 4 Stein PD, Alpert JS, Copeland JG, Dalen JE, Turpie AGG. Antithrombotic therapy in patients with mechanical and bioprosthetic heart valves. Chest 1995; 108: 371S-379S
    CrossrefPubMedGoogle Scholar
  • 5 Cevese PG. Long-term results of 212 xenograft valve replacements. J Cardiovasc Surg 16 1975; 639-642
    PubMedGoogle Scholar
  • 6 Pipkin RD, Buch WS, Fogarty TS. Evaluation of aortic valve replacement with a porcine xenograft without long-term anticoagulation. J Thorac Cardiovasc Surg 71 1976; 179-186
    PubMedGoogle Scholar
  • 7 Stinson EB, Griepp RB, Oyer PE. et al. Long-term experience with porcine aortic valve xenografts. J Thorac Cardiovasc Surg 1977; 73: 54-63
    PubMedGoogle Scholar
  • 8 Ionescu MI, Pakrashi BC, Mary DAS. et al. Long-term evaluation of tisue valves. J Thorac Cardiovasc Surg 68 1974; 361-379
    PubMedGoogle Scholar
  • 9 Hull R, Delmore T, Genton E. et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 301 1979; 855-858
    CrossrefPubMedGoogle Scholar
  • 10 Hull R, Hirsh J, Jay R, Carter C, England C, Gent M, Turpie AGG. et al: Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. N Engl J Med 307: 1676-1681 1982;
    CrossrefPubMedGoogle Scholar
  • 11 Hull R, Delmore T, Carter C. et al: Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 306: 189-194 1982;
    CrossrefPubMedGoogle Scholar
  • 12 Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 108 (04) 1995; 335S-351S
    CrossrefPubMedGoogle Scholar
  • 13 Turpie AGG, Gunstensen J, Hirsh J, Nelson H, Gent M. A randomized trial comparing two intensities of oral anticoagulant therapy following tissue heart valve replacement. Lancet 01: 1242-1245 1988;
    PubMedGoogle Scholar
  • 14 Saour JN, Sieck JO, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 332 1990; 428-432
    PubMedGoogle Scholar
  • 15 Altman P, Rouvier J, Gurfinkel E. et al. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991; 101: 427-431
    PubMedGoogle Scholar
  • 16 Acar J, lung B, Boissel JP. et al. AREVA: Multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996; 94 (09) 2107-2112
    CrossrefPubMedGoogle Scholar
  • 17 Cannegieter SC, Rosendaal FR, Wintzen AR. et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333 (01) 11-17
    CrossrefPubMedGoogle Scholar
  • 18 Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac valve replacement. N Engl J Med 1971; 284: 1391-1394
    CrossrefPubMedGoogle Scholar
  • 19 Chesebro JG, Fuster V, Elveback LR. et al. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51 1983; 1537-1541
    CrossrefPubMedGoogle Scholar
  • 20 Pouleur H, Buyse M. Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials. J Thorac Cardiovasc Surg 110: 463-466 1995;
    CrossrefPubMedGoogle Scholar
  • 21 Dale J, Myhre E, Storstein O. et al. Prevention of arterial thromboembolism with acetylsalicyl acid: A controlled clinical study in patients with aortic ball valves. Am Heart J 1977; 94: 101-111
    CrossrefPubMedGoogle Scholar
  • 22 Hirsh J, Dalen JE, Fuster V, Harker L, Patrono C, Roth GJ. Aspirin and other platelet-active drugs: The relationship between dose, effectiveness and side effects. Chest 1995; 108: 247S-257S
    CrossrefPubMedGoogle Scholar
  • 23 Turpie AGG, Gent M, Laupacis A. et al. A double-blind randomized trial of acetylsalicylic acid (100 mg) versus placebo in patients treated with oral anticoagulants following heart valve replacement. N Engl J Med 1991; 329: 1365-1369
    PubMedGoogle Scholar
  • 24 Altman R, Rouvier J, Gurfinkel E, Scazziota A, Turpie AGG. Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 94 (09) 2113-2116 1996;
    CrossrefPubMedGoogle Scholar
  • 25 Hayashi JI, Nakazawa S, Oguma F, Miyamura H, Eguchi S. Combined warfarin and antiplatelet therapy after St. Jude mechanical vale replacement for mitral valve disease. JACC 23 1994; 672-677
    CrossrefPubMedGoogle Scholar